Case Study · Telehealth
Fella Health — Built For Bigger Guys
Convinced men who’d given up that weight loss was finally built for them — and scaled it profitably.
Client
Fella Health
Industry
Telehealth / DTC
Channel
Meta Ads
Services
Creative Strategy · Paid Social
The Challenge
A market that had already given up
Fella Health does one thing: GLP-1 weight loss, Semaglutide and the rest, built for men. The GLP-1 boom was real, but it arrived wrapped in friction — waiting lists, gatekeeping — and marketing that spoke to everyone except the men who needed it most. Worse, the men Fella needed to reach had mostly stopped trying. They’d been through every diet and concluded, flatly, that nothing works for guys their size.
Fella wanted to own men’s weight loss and scale it profitably — cost per acquisition under $300, held as spend climbed. The creative job wasn’t to sell a product. It was to change a belief.
The Customer
Bigger guys who’d stopped believing
I built the audience from the real friction in the category — what bigger men actually feel about weight loss — pulled from review mining and men’s-health forums. The objection wasn’t vanity. It was disbelief: a settled conviction that weight loss simply doesn’t work for someone their size, stacked on top of the hassle of actually getting GLP-1.
“Steve”, 40s — tried everything
Driver: wants something that finally works for a body his size.
Hesitation: “there’s literally no way for bigger guys like me to lose weight” — and assumes GLP-1 is gatekept and waitlisted anyway.
Job to be done: proof it works for men his size, and a fast, easy way in.
“Mark”, 38 — time-poor, curious
Driver: has heard GLP-1 works and wants in, but won’t jump through hoops for it.
Hesitation: waiting lists, admin, and a nagging “what if I pay and it doesn’t work for me.”
Job to be done: instant access and a reason to trust it’s worth the money.
The Angles
Answer the objection, four ways
Core message: weight loss that’s actually built for bigger guys — and easy to start. Four angles, each aimed at a different reason men had counted themselves out.
- “Oh yes there is” — built for bigger guys (winner) — meets the “nothing works for me” belief head-on, in Fella’s confident, slightly cheeky brand voice.
- 22.5% — proof it works — a concrete efficacy number for bigger guys, not a generic before-and-after.
- Skip the waiting list — access GLP-1 now, killing the friction objection.
- Money-back guarantee — don’t lose weight, get it all back. Removes the risk of wasting money on one more thing.
The Creative
Meet them where they scroll
The work lived in the formats these men actually use. An iMessage exchange voiced the objection out loud, then answered it. A Twitter reply let Fella clap back at a guy who’d declared it hopeless — “Oh yes there is.” Around them, bold typographic statics put the Semaglutide and GLP-1 vials front and centre in Fella’s green, each carrying one sharp promise: access, efficacy, money back. Motion — a spinning vial, animated drug names — added stopping power. Cheeky where it earned it, credible where it counted.
The Approach
Test the angle and the format
Disciplined iterative testing across both angle and format. The native-format ads — iMessage, Twitter — were the scroll-stoppers for cold, skeptical men; the product-and-guarantee statics converted the warmer ones. Every test changed one lever, so we always knew what moved the number. As the market warmed to GLP-1, the messaging shifted from explaining the science to leading with access and risk reversal, and creative output scaled from 5 to 40 ads a month to feed it.
The Results
Answering the real objection — does it work for me, can I actually get it, what if it doesn’t — turned disbelief into sign-ups. CPA came under the brand’s commercial line and held there as spend scaled, clearing the runway for national growth.
−54% CPA
Cut to ~$240 at scale, from ~$520 — under the $300 target.
3× spend
Tripled budget with CPA still falling. Efficient scale, not bought volume.
5 → 40
Ads per month — 4–8× the testing throughput, same timelines.
Efficiency held while spend scaled — the only kind of result a CFO actually believes.
The Takeaway
When a market has given up, you’re not selling a product — you’re changing a belief. By meeting bigger guys in their own formats and answering their real objection, Fella turned “nothing works for me” into sign-ups, profitably. Strategy-led creative moves a number and a mindset.
Got a number that needs moving?
Chris Hallam 